Growth Metrics

Harvard Bioscience (HBIO) Equity Income (2023 - 2024)

Harvard Bioscience (HBIO) has disclosed Equity Income for 2 consecutive years, with -$281000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Equity Income rose 82.23% to -$281000.0 in Q2 2024 year-over-year; TTM through Mar 2025 was -$281000.0, a 85.55% increase, with the full-year FY2024 number at -$1.6 million, down 152.06% from a year prior.
  • Equity Income was -$281000.0 for Q2 2024 at Harvard Bioscience, up from -$1.3 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $1.2 million in Q3 2023 to a low of -$1.6 million in Q2 2023.